For PFAAs a rat study showed that multiple proteins in the liver are capable for specific binding to PFOA, but those proteins were not specified [ 45].
This view is supported by recent rat studies showing that areas 29 and 30 jointly support the same overall classes of learning, e.g., spatial memory, but make different contributions (van Groen et al., 2004; Vann and Aggleton, 2005; Pothuizen et al., 2009, 2010).
In vivo rat studies show complete graft patency at all time points, rapid endothelialization, and stabilization and contraction of neointimal hyperplasia.
In vivo rat studies show that HAMC is biocompatible within the intrathecal space for 1 month, and may provide therapeutic benefit, in terms of behavior, as measured by the Basso, Beattie and Bresnahan (BBB) locomotor scale, and inflammation.
Rat studies showed that perfluorinated compounds (PFCs) cause significantly increase in mammary fibroadenomas.
Rat studies show that the development of low-grade inflammation negatively affects muscle mass and attenuates the muscle protein synthesis response to feeding [ 4, 5].
Laboratory rat studies showed elevated levels of 8-OHdG in urine following exposure to DBP or butyl benzyl phthalate (BzBP) and mBP; nevertheless, a significant positive relationship was only found between urinary 8-OHdG and mEHP or miBP levels in our study.
Additional rat studies showed that the gas phase alone was not acutely toxic and that aging of the PTFE fume particles for 3 min increased their particle size to > 100 nm because of accumulation, which resulted in a loss of toxicity (Johnston et al. 2000).
The present study shows that ezlopitant treatment significantly decreases ethanol consumption in rats, supporting a study showing that NK1-receptor knock-out mice have markedly lower ethanol consumption than wild-type controls [36].
In the current rat study, nodes showing increased uptake contained 0.109% ± 0.067% (mean % per node) of the initial dose of 7.4 MBq.
